Taihe Group, Inc.
OTC: TIHE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yan Ping Sheng
- Employees
- 3
- Headquarters
- Scottsdale, United States
- IPO year
- 1998
- Market cap
- $71.9M
Loading TIHE…
Loading profile data…Frequently asked questions about TIHE
What does Taihe Group, Inc. (TIHE) do?
Currently, Taihe Group, Inc. is not engaged in substantial operational activities. Historically, the company functioned as a commercial laboratory, providing specialized predictive tests for chemosensitivity and immunotherapy on biopsy samples, alongside a variety of other laboratory services and products within the field of oncology. Establishe...
Where does TIHE trade?
Taihe Group, Inc. (TIHE) trades on the Other OTC.
What sector is TIHE in?
Taihe Group, Inc. (TIHE) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Taihe Group, Inc.?
Yan Ping Sheng is the chief executive officer of Taihe Group, Inc. (TIHE).
Where is Taihe Group, Inc. headquartered?
Taihe Group, Inc. is headquartered in United States.
Does TIHE pay a dividend?
Taihe Group, Inc. (TIHE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TIHE go public?
Taihe Group, Inc. (TIHE) completed its initial public offering in 1998.